Open original FDA record ↗Recall record
- FDA identifier
- Z-2159-2012
- Company in FDA record
- Roche Molecular Systems, Inc.
- FDA classification date
- Aug 8, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class III
Reason stated in the source
During the real-time stability testing for the cobas KRAS Mutation Test on the commercial lot PO6778, it was identified that the kit was just within specifications for the codon 61 peak height ratio, and that the kit has trended towards the upper specification limit at the 6 month time point but did passed the 6 month stability testing. The kit is labeled for 9 months shelf life stability. The d
Source facts
- Action
- Roche issued a Safety Board Notice (Prooduct Support Notice 2012-01) and Product Bulletin 2012/03 dated February 24, 2012 to all affected customers. The notice idenfied the affected product, description of situation and actions to be taken. Customers were instructed to discontinue use of lot P06778 by March 4, 2012 and to quarantine and discard any remaining kits from lot P06778. The notice stated that a new lot will be made available as a replacement.
- Initiated
- 2012-02-24
- Root cause
- Nonconforming Material/Component
- Terminated
- 2013-07-16
- Distribution
- Worldwide Distribution - including the countries of Austria, Belgium, Czech Republic, Denmark, Germany, Italy, Luxemburg, Netherlands, Poland, Slovakia, Slovenia, Spain, United Kingdom, Canada, Chile, Greenland, Hong Kong, Israel, Malaysia, New Zealand, Philippines, S. Africa, Switzerland, Taiwan and Turkey.
- Recall number
- Z-2159-2012
- Recall status
- Terminated
- CDRH record ID
- 110910
- FDA classified
- 2012-08-08
- Recall event number
- 62500